Junshi Biosciences Announces 2024 Full Year Financial Results and Provides Corporate Updates


SHANGHAI, March 28, 2025 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial results for the full year of 2024 and provided corporate updates.

See the rest here:
Junshi Biosciences Announces 2024 Full Year Financial Results and Provides Corporate Updates

Related Posts